Carcinoid tumors of the extrahepatic bile ducts: A study of seven cases

American Journal of Surgical Pathology

Volumn 24, Issue 11, 2000, Pages 1501-1510

  Maitra, Anirban ^a   Krueger, Jo Ellen ^a   Tascilar, Metin ^b   Offerhaus, G Johan A ^b   Angeles Angeles, Arturo ^c   Klimstra, David S ^d   Hruban, Ralph H ^e   Albores Saavedra, Jorge ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Carcinoid tumors; Electron microscopy; Extrahepatic bile ducts; Immunohistochemistry; K ras genes; p53

Indexed keywords

CHROMOGRANIN; PANCREAS POLYPEPTIDE; PROTEIN P53; SEROTONIN; SOMATOSTATIN; SYNAPTOPHYSIN;

ADULT; ARTICLE; CARCINOID; CLINICAL ARTICLE; CLINICAL FEATURE; CODON; COMMON BILE DUCT; ELECTRON MICROSCOPY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NEUROSECRETORY CELL; OBSTRUCTIVE JAUNDICE; ONCOGENE K RAS; PANCREATICODUODENECTOMY; PATHOGENESIS; PRURITUS;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CARCINOID TUMOR; CHROMOGRANINS; CYTOPLASMIC GRANULES; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GASTRINS; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; LYMPH NODES; LYMPHATIC METASTASIS; MICROSATELLITE REPEATS; MIDDLE AGED; NEUROSECRETORY SYSTEMS; PANCREATIC POLYPEPTIDE; PANCREATICODUODENECTOMY; SEROTONIN; SMAD4 PROTEIN; SOMATOSTATIN; SYNAPTOPHYSIN; TRANS-ACTIVATORS; TREATMENT OUTCOME;

EID: 0033759243     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200011000-00005     Document Type: Article

References (58)

1. Well differentiated adenocarcinoma, gastric foveolar type, of the extrahepatic bile ducts: A previously unrecognized and distinctive morphologic variant of bile duct carcinoma
2. Primary common bile duct carcinoid: Demonstration by computed tomography, ultrasonography and angiography
3. Primary carcinoid of the common bile duct. Immunohistochemical characterization of a case and review of literature
4. Carcinoid tumor of the common bile duct
5. Carcinoid tumor of the common bile duct: Evidence for its origin in metaplastic endocrine cells
6. Alterations in DNA methylation: A fundamental aspect of neoplasia
7. Primary extrahepatic bile duct carcinoids
8. Carcinoid tumors of the biliary tract
9. Carcinoid of the biliary tree: A case report and review of the literature
10. Carcinoid tumor of the bile duct. A case report and literature review
11. Carcinoid tumor of the biliary duct
12. Carcinoid of the cystic duct
13. Clinical significance of K-ras oncogene activation in ampullary neoplasms
14. Carcinoid tumor (argentaffinomata)
15. Carcinoid tumor of the common bile duct - A novel complication of von Hippel-Lindau syndrome
16. Carcinoid tumor of the bile duct: Case report
17. Obstructive jaundice caused by a carcinoid tumor of the hepatocholedochal duct
18. Carcinoid of the intrahepatic ducts
19. Primary common bile duct carcinoid
20. Somatostatinoma of the cystic duct
21. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
22. Carcinoid tumor of the common bile duct producing gastrin and serotonin
23. Carcinoid tumor of the cystic duct
24. Common bile duct carcinoid
25. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients
26. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis
27. Carcinoid tumor of the biliary system. Case report and literature review
28. Carcinoid tumor of the common bile duct
29. Primary common bile duct carcinoid
30. Gastrinoma of the common bile duct: Immunohistochemical and ultrastructural study of a case
31. Carcinoid tumor of the common bile duct: Report of a case
32. Carcinoid tumor of the cystic duct
33. Genetic changes in the spectrum of neuroendocrine lung tumors
34. Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids
35. Carcinoid tumor of common hepatic duct
36. Uber ein karzinoid des ductus choledochus
37. p53 Expression as a prognostic determinant in resected distal bile duct carcinoma
38. Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma
39. Carcinoid of the common bile duct: A case report and literature review
40. The INK4 family of cell cycle inhibitors in cancer
41. Tumor-suppressive pathways in pancreatic carcinoma
42. Primary carcinoid tumor of the cystic and common bile ducts
43. Carcinoid tumors of the extrahepatic bile duct: An unusual cause of bile duct obstruction
44. Carcinoid tumor of the bile ducts
45. Carcinoid tumor of the cystic duct
46. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct
47. Carcinoid tumor arising in the wall of a congenital bile duct cyst
48. Case report: Fourteen-year follow-up of an apudoma of the bile ducts at the hilum of the liver
49. Carcinoid tumor of the common bile duct
50. Neuroendocrine neoplasms of the lung are not associated with point mutations at codon 12 of the K-ras gene
51. Point mutation of K-ras gene codon 12 in biliary tract tumors
52. Molecular abnormalities associated with endocrine tumors of the uterine cervix
53. Primary carcinoid of the choledochus
54. Endocrine cell carcinoma (carcinoid) of the gallbladder
55. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers
56. A case of carcinoid tumor of the common hepatic duct
57. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors